First-in-humans phase I trial of O 304.

Trial Profile

First-in-humans phase I trial of O 304.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Feb 2015

At a glance

  • Drugs O 304 (Primary)
  • Indications Diabetic complications; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Peripheral arterial disorders; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Betagenon
  • Most Recent Events

    • 02 Feb 2015 According to Betagenon media release, status changed from recruiting to completed.
    • 12 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top